pharma news

News

Beeline raises $300m for BMS drugs, and other biofinancings

Beeline Medicines, Oricell, Terremoto, Harbinger, Neomorph, Adcendo, and STORM all closed impressive financing rounds in the last week.

News

Most patients "won't see benefit" with Alzheimer's drugs

A review of clinical data on amyloid-targeting Alzheimer's therapies has found absent or trivial efficacy, but is facing pushback from some experts.

News

Novartis CEO joins board of "responsible" AI firm Anthropic

In another signal of the deepening relationship between the pharma and AI sectors, Novartis CEO Vas Narasimhan has joined the board of Anthropic.

News

Scientists issue call to arms over antifungal resistance

Infectious disease experts from around the world are calling for concerted action to combat a "silent surge" in resistance to antifungal drugs.

News

Daiichi exits OTC, with $1.55bn unit sale to Suntory

Daiichi Sankyo has agreed to sell its consumer health unit to food and beverage giant Suntory, following a well-trodden path for big pharma companies.

News

Parkinson's charity partners Biognosys on biomarker project

A new R&D project will try to develop assays for LRRK2, a biomarker linked to Parkinson's that has emerged as a major drug target in the disease.

Beeline raises $300m for BMS drugs, and other biofinancings

Most patients "won't see benefit" with Alzheimer's drugs

Novartis CEO joins board of "responsible" AI firm Anthropic

Scientists issue call to arms over antifungal resistance

Daiichi exits OTC, with $1.55bn unit sale to Suntory

Parkinson's charity partners Biognosys on biomarker project

GBL joins CVC in €10.7bn takeover bid for Recordati

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks